Unicycive Announces First Quarter 2024 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. SPCX
2. CRNX
3. VRTX
4. WMT
5. LMT
6. RXST
7. SPGI
8. RIVN
9. SPY
10. BFH

Go back to Unicycive Announces First Quarter 2024 Financial Results and Provides Business Update

Noble Capital Reiterates Outperform Rating on Unicycive Therapeutics (UNCY)

May 14, 2024 8:44 AM EDT

Noble Capital analyst Robert LeBoyer reiterated an Outperform rating and $6.00 price target on Unicycive Therapeutics (NASDAQ: UNCY).

The analyst comments "We Believe OLC Will Have Advantages Over Other Phosphate Binding Drugs.
OLC was formulated to reduce pill burden and improve compliance in... More